BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2423349)

  • 1. Effects of complex extracellular matrices on 5-azacytidine-induced myogenesis.
    Scott-Burden T; Bogenmann E; Jones PA
    Exp Cell Res; 1986 Jun; 164(2):527-35. PubMed ID: 2423349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen concentration regulates 5-azacytidine-induced myogenesis in C3H/10T1/2 cultures.
    Storch TG
    Biochim Biophys Acta; 1990 Nov; 1055(2):126-9. PubMed ID: 1700726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of myogenic cell lines derived by 5-azacytidine treatment.
    Liu L; Harrington M; Jones PA
    Dev Biol; 1986 Oct; 117(2):331-6. PubMed ID: 2428680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans synthesized by cultured bovine corneal endothelial cells.
    Robinson J; Gospodarowicz D
    J Cell Physiol; 1983 Dec; 117(3):368-76. PubMed ID: 6418749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagenous substrata regulate the nature and distribution of glycosaminoglycans produced by differentiated cultures of mouse mammary epithelial cells.
    Parry G; Lee EY; Farson D; Koval M; Bissell MJ
    Exp Cell Res; 1985 Feb; 156(2):487-99. PubMed ID: 3917927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glycosaminoglycans and extracellular matrix components on metastatic rat rhabdomyosarcoma tumor and myoblast cell proliferation.
    Redini F; Moczar E; Poupon MF
    Clin Exp Metastasis; 1990; 8(5):491-502. PubMed ID: 2390814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular smooth muscle cell phenotype influences glycosaminoglycan composition and growth effects of extracellular matrix.
    Hein M; Fischer J; Kim DK; Hein L; Pratt RE
    J Vasc Res; 1996; 33(6):433-41. PubMed ID: 8998192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell matrices modulate smooth muscle cell growth, contractile phenotype and sensitivity to heparin.
    Herman IM
    Haemostasis; 1990; 20 Suppl 1():166-77. PubMed ID: 2083870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine.
    Wakitani S; Saito T; Caplan AI
    Muscle Nerve; 1995 Dec; 18(12):1417-26. PubMed ID: 7477065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteoglycans in primate arteries. II. Synthesis and secretion of glycosaminoglycans by arterial smooth muscle cells in culture.
    Wight TN; Ross R
    J Cell Biol; 1975 Dec; 67(3):675-86. PubMed ID: 127802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.
    Castellot JJ; Addonizio ML; Rosenberg R; Karnovsky MJ
    J Cell Biol; 1981 Aug; 90(2):372-9. PubMed ID: 7287812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmentally regulated changes in extracellular matrix in endothelial and smooth muscle cells in the ductus arteriosus may be related to intimal proliferation.
    Boudreau N; Rabinovitch M
    Lab Invest; 1991 Feb; 64(2):187-99. PubMed ID: 1997732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of extracellular matrix-associated glycosaminoglycans produced by untransformed and transformed bovine corneal endothelial cells in culture.
    Wang ZW; Irimura T; Nakajima M; Belloni PN; Nicolson GL
    Eur J Biochem; 1985 Nov; 153(1):125-30. PubMed ID: 2998789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levels of vascular smooth as well as skeletal muscle actin mRNAs differ substantially among both myoblast and fibroblast lines with different skeletal myogenic potentials.
    Sharp SB; Vazquez A; Theimer M; Silva DK; Muscati SR; Sylber M; Mogassa M
    Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):903-13. PubMed ID: 1477607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levels of vascular smooth as well as skeletal muscle actin mRNAS differ substantially among both myoblast and fibroblast lines with different skeletal myogenic potentials.
    Sharp SB; Vazquez A; Theimer M; Silva DK; Muscati SR; Sylber M; Mogassa M
    Cell Mol Biol; 1992 Aug; 38(5):485-504. PubMed ID: 1468109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culturing chick muscle cells on glycosaminoglycan substrates: attachment and differentiation.
    Kujawa MJ; Tepperman K
    Dev Biol; 1983 Oct; 99(2):277-86. PubMed ID: 6413281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix: differential influence on growth and biosynthesis patterns of vascular smooth muscle cells from SHR and WKY rats.
    Scott-Burden T; Resink TJ; Bürgin M; Bühler FR
    J Cell Physiol; 1989 Nov; 141(2):267-74. PubMed ID: 2808537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine.
    Taylor SM; Jones PA
    Cell; 1979 Aug; 17(4):771-9. PubMed ID: 90553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface glycosaminoglycans (GAGs) of cultured chick fibroblasts. Modifications in relation to the stage of embryo development.
    Berjonneau C; Aubery M
    Exp Cell Res; 1985 Apr; 157(2):475-82. PubMed ID: 3920062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfated glycosaminoglycans synthesized by fibroblast, smooth muscle and endothelium-like cells grown in culture.
    Mourão PA; Pillai S; Donnelly PV
    Cell Differ; 1983 Feb; 12(2):99-108. PubMed ID: 6600153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.